INDIANAPOLIS, Ind. — Indianapolis-based Eli Lilly is pausing its trial of antibody treatment for coronavirus “out of an abundance of caution.”. It’s unclear exactly what happened to prompt the company to pause its trial. “Safety is of the utmost importance to Lilly,” a statement from Eli Lilly reads. “We are...
The article aroused the public's notice and enthusiastic discussion. What do you think? Let us know more about your opinion down below in the comments.